Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFFGet Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 5,800 shares, a growth of 100.0% from the September 30th total of 2,900 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Price Performance

Laboratorios Farmaceuticos Rovi stock remained flat at C$90.61 during mid-day trading on Monday. Laboratorios Farmaceuticos Rovi has a 1-year low of C$90.61 and a 1-year high of C$90.61. The stock has a fifty day moving average of C$90.61 and a 200 day moving average of C$88.75.

About Laboratorios Farmaceuticos Rovi

(Get Free Report)

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.

Featured Stories

Receive News & Ratings for Laboratorios Farmaceuticos Rovi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratorios Farmaceuticos Rovi and related companies with MarketBeat.com's FREE daily email newsletter.